Search

everythinglearnresearchcommunity

for

Search:↓

The combined treatment improved hair growth and scalp health in a patient with scalp alopecia from birth.

Platelet-rich plasma can help grow more mouse hair follicles, but it doesn't work for human hair follicles yet.

PRP injections effectively treat hair loss, with positive results in both monthly and every three months treatments.

Dermatologists should be aware of and manage alopecia risks from certain cosmetic procedures.

PRP injections can increase hair density in people with androgenic alopecia.

PRP injections improve hair thickness for baldness.

Testosterone therapy helps boys with hormone deficiencies develop normal male characteristics and grow properly.

Medical aesthetics now helps treat medical conditions, expanding options for dermatologists.

Fat grafting is more effective and safer for correcting jowls than ligament release.

Nanofat injections before hair transplantation improve eyebrow restoration in burn scars.

PRP injections may be a safe, effective alternative for hair loss treatment compared to minoxidil and finasteride.

Oral testosterone therapy raises heart risk more than other methods.

PRP injections promote hair growth and increase hair density in androgenic alopecia.

Botulinum toxin can safely and effectively treat facial wrinkles and muscle issues with precise injection techniques.

Platelet-rich plasma, microneedling with minoxidil, and topical finasteride are promising treatments for hair loss.

Stem cell therapies could be a promising alternative for hair loss treatment, but more research is needed to understand their full potential and safety.

Proper planning and technique in upper-face feminization surgery are crucial to avoid complications and revisions.

Using Platelet-Rich Plasma injections for male-pattern baldness didn't significantly improve hair growth.

Platelet-rich plasma (PRP) is an effective treatment for hair loss that involves scalp injections and requires ongoing maintenance.

Platelet-Rich Plasma (PRP) therapy can promote hair growth and improve facial aesthetics, including reducing acne scars and facial burns, and it works best with three initial monthly injections.

Blood pressure drugs can cause skin lupus, but it improves after stopping the drug. The glycoprotein D vaccine works against genital herpes in some women, and the HPV-16 vaccine reduces HPV-16 infection and related diseases. More frequent light therapy clears psoriasis faster. A cream called imiquimod effectively treats a type of skin cancer. Iron supplements don't necessarily help with chronic hair loss in women.

Various skin conditions like cutaneous lupus erythematosus, psoriasis, and basal cell carcinoma can be effectively treated with antihypertensive agents, NB-UVB phototherapy, and imiquimod cream respectively. Vaccines are effective against genital herpes and HPV-16 infection. Early intervention is crucial for conditions like diabetic foot ulcers and neonatal herpes. Certain dyes can cause hand dermatitis, and there's a link between smoking/drinking and psoriasis in men. No direct link was found between low iron levels and chronic hair loss in women.

Filler injections can cause temporary hair loss, but hyaluronidase can help restore hair within a few months.

Hyaluronic acid injections can improve mouth opening and quality of life in scleroderma patients.

PDLLA scalp injections improved hair regrowth in most patients with non-scarring alopecia.

Human fetal placental stromal cell injections speed up healing and improve skin and hair recovery after radiation damage.

Subcutaneous contraceptives can cause side effects like menstrual changes, headaches, weight gain, and pain at the implant site.

Tumescent fluid increases scalp hair angles, which may improve hair transplant results and reduce surgeon fatigue.

New techniques and technologies are improving facial plastic and reconstructive surgery.

Cosmetic surgery is more popular and cost-effective, but outcomes depend on the surgeon's skill and all procedures have potential complications.